The Market Reports

Index

1 Neuroprotective Products Market Overview
1.1 Product Overview and Scope of Neuroprotective Products
1.2 Neuroprotective Products Segment by Type
1.2.1 Global Neuroprotective Products Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Cholinesterase inhibitors
1.2.3 NMDA receptor antagonists
1.2.4 Others
1.3 Neuroprotective Products Segment by Application
1.3.1 Global Neuroprotective Products Sales Comparison by Application: (2021-2027)
1.3.2 Alzheimer's disease
1.3.3 Multiple sclerosis
1.3.4 Others
1.4 Global Neuroprotective Products Market Size Estimates and Forecasts
1.4.1 Global Neuroprotective Products Revenue 2016-2027
1.4.2 Global Neuroprotective Products Sales 2016-2027
1.4.3 Neuroprotective Products Market Size by Region: 2016 Versus 2021 Versus 2027

2 Neuroprotective Products Market Competition by Manufacturers
2.1 Global Neuroprotective Products Sales Market Share by Manufacturers (2016-2021)
2.2 Global Neuroprotective Products Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Neuroprotective Products Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Neuroprotective Products Manufacturing Sites, Area Served, Product Type
2.5 Neuroprotective Products Market Competitive Situation and Trends
2.5.1 Neuroprotective Products Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Neuroprotective Products Players Market Share by Revenue
2.5.3 Global Neuroprotective Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Neuroprotective Products Retrospective Market Scenario by Region
3.1 Global Neuroprotective Products Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Neuroprotective Products Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Neuroprotective Products Market Facts & Figures by Country
3.3.1 North America Neuroprotective Products Sales by Country
3.3.2 North America Neuroprotective Products Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Neuroprotective Products Market Facts & Figures by Country
3.4.1 Europe Neuroprotective Products Sales by Country
3.4.2 Europe Neuroprotective Products Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Neuroprotective Products Market Facts & Figures by Region
3.5.1 Asia Pacific Neuroprotective Products Sales by Region
3.5.2 Asia Pacific Neuroprotective Products Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Neuroprotective Products Market Facts & Figures by Country
3.6.1 Latin America Neuroprotective Products Sales by Country
3.6.2 Latin America Neuroprotective Products Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Neuroprotective Products Market Facts & Figures by Country
3.7.1 Middle East and Africa Neuroprotective Products Sales by Country
3.7.2 Middle East and Africa Neuroprotective Products Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Neuroprotective Products Historic Market Analysis by Type
4.1 Global Neuroprotective Products Sales Market Share by Type (2016-2021)
4.2 Global Neuroprotective Products Revenue Market Share by Type (2016-2021)
4.3 Global Neuroprotective Products Price by Type (2016-2021)

5 Global Neuroprotective Products Historic Market Analysis by Application
5.1 Global Neuroprotective Products Sales Market Share by Application (2016-2021)
5.2 Global Neuroprotective Products Revenue Market Share by Application (2016-2021)
5.3 Global Neuroprotective Products Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Genervon
6.1.1 Genervon Corporation Information
6.1.2 Genervon Description and Business Overview
6.1.3 Genervon Neuroprotective Products Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Genervon Neuroprotective Products Product Portfolio
6.1.5 Genervon Recent Developments/Updates
6.2 NeuroVive Pharmaceutical
6.2.1 NeuroVive Pharmaceutical Corporation Information
6.2.2 NeuroVive Pharmaceutical Description and Business Overview
6.2.3 NeuroVive Pharmaceutical Neuroprotective Products Sales, Revenue and Gross Margin (2016-2021)
6.2.4 NeuroVive Pharmaceutical Neuroprotective Products Product Portfolio
6.2.5 NeuroVive Pharmaceutical Recent Developments/Updates
6.3 Ceregene
6.3.1 Ceregene Corporation Information
6.3.2 Ceregene Description and Business Overview
6.3.3 Ceregene Neuroprotective Products Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Ceregene Neuroprotective Products Product Portfolio
6.3.5 Ceregene Recent Developments/Updates
6.4 BHR Pharma
6.4.1 BHR Pharma Corporation Information
6.4.2 BHR Pharma Description and Business Overview
6.4.3 BHR Pharma Neuroprotective Products Sales, Revenue and Gross Margin (2016-2021)
6.4.4 BHR Pharma Neuroprotective Products Product Portfolio
6.4.5 BHR Pharma Recent Developments/Updates
6.5 Neuren Pharmaceuticals
6.5.1 Neuren Pharmaceuticals Corporation Information
6.5.2 Neuren Pharmaceuticals Description and Business Overview
6.5.3 Neuren Pharmaceuticals Neuroprotective Products Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Neuren Pharmaceuticals Neuroprotective Products Product Portfolio
6.5.5 Neuren Pharmaceuticals Recent Developments/Updates
6.6 Allon therapeutics
6.6.1 Allon therapeutics Corporation Information
6.6.2 Allon therapeutics Description and Business Overview
6.6.3 Allon therapeutics Neuroprotective Products Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Allon therapeutics Neuroprotective Products Product Portfolio
6.6.5 Allon therapeutics Recent Developments/Updates
6.7 Bionure
6.6.1 Bionure Corporation Information
6.6.2 Bionure Description and Business Overview
6.6.3 Bionure Neuroprotective Products Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Bionure Neuroprotective Products Product Portfolio
6.7.5 Bionure Recent Developments/Updates

7 Neuroprotective Products Manufacturing Cost Analysis
7.1 Neuroprotective Products Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Neuroprotective Products
7.4 Neuroprotective Products Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Neuroprotective Products Distributors List
8.3 Neuroprotective Products Customers

9 Neuroprotective Products Market Dynamics
9.1 Neuroprotective Products Industry Trends
9.2 Neuroprotective Products Growth Drivers
9.3 Neuroprotective Products Market Challenges
9.4 Neuroprotective Products Market Restraints

10 Global Market Forecast
10.1 Neuroprotective Products Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Neuroprotective Products by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Neuroprotective Products by Type (2022-2027)
10.2 Neuroprotective Products Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Neuroprotective Products by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Neuroprotective Products by Application (2022-2027)
10.3 Neuroprotective Products Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Neuroprotective Products by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Neuroprotective Products by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Neuroprotective Products Sales (MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Neuroprotective Products Sales (MT) Comparison by Application (2021-2027)
Table 3. Global Neuroprotective Products Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Neuroprotective Products Covered in This Study
Table 5. Global Neuroprotective Products Sales (MT) of Key Manufacturers (2016-2021)
Table 6. Global Neuroprotective Products Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Neuroprotective Products Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Neuroprotective Products Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Neuroprotective Products Average Price (USD/Kg) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Neuroprotective Products Manufacturing Sites and Area Served
Table 11. Manufacturers Neuroprotective Products Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Neuroprotective Products by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuroprotective Products as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Neuroprotective Products Sales by Region (2016-2021) & (MT)
Table 16. Global Neuroprotective Products Sales Market Share by Region (2016-2021)
Table 17. Global Neuroprotective Products Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Neuroprotective Products Sales by Country (2016-2021) & (MT)
Table 19. North America Neuroprotective Products Sales Market Share by Country (2016-2021)
Table 20. North America Neuroprotective Products Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Neuroprotective Products Revenue Market Share by Country (2016-2021)
Table 22. Europe Neuroprotective Products Sales by Country (2016-2021) & (MT)
Table 23. Europe Neuroprotective Products Sales Market Share by Country (2016-2021)
Table 24. Europe Neuroprotective Products Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Neuroprotective Products Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Neuroprotective Products Sales by Region (2016-2021) & (MT)
Table 27. Asia Pacific Neuroprotective Products Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Neuroprotective Products Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Neuroprotective Products Revenue Market Share by Region (2016-2021)
Table 30. Latin America Neuroprotective Products Sales by Country (2016-2021) & (MT)
Table 31. Latin America Neuroprotective Products Sales Market Share by Country (2016-2021)
Table 32. Latin America Neuroprotective Products Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Neuroprotective Products Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Neuroprotective Products Sales by Country (2016-2021) & (MT)
Table 35. Middle East and Africa Neuroprotective Products Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Neuroprotective Products Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Neuroprotective Products Revenue Market Share by Country (2016-2021)
Table 38. Global Neuroprotective Products Sales (MT) by Type (2016-2021)
Table 39. Global Neuroprotective Products Sales Market Share by Type (2016-2021)
Table 40. Global Neuroprotective Products Revenue (Million US$) by Type (2016-2021)
Table 41. Global Neuroprotective Products Revenue Share by Type (2016-2021)
Table 42. Global Neuroprotective Products Price (USD/Kg) by Type (2016-2021)
Table 43. Global Neuroprotective Products Sales (MT) by Application (2016-2021)
Table 44. Global Neuroprotective Products Sales Market Share by Application (2016-2021)
Table 45. Global Neuroprotective Products Revenue (Million US$) by Application (2016-2021)
Table 46. Global Neuroprotective Products Revenue Share by Application (2016-2021)
Table 47. Global Neuroprotective Products Price (USD/Kg) by Application (2016-2021)
Table 48. Genervon Corporation Information
Table 49. Genervon Description and Business Overview
Table 50. Genervon Neuroprotective Products Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 51. Genervon Neuroprotective Products Product
Table 52. Genervon Recent Developments/Updates
Table 53. NeuroVive Pharmaceutical Corporation Information
Table 54. NeuroVive Pharmaceutical Description and Business Overview
Table 55. NeuroVive Pharmaceutical Neuroprotective Products Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 56. NeuroVive Pharmaceutical Neuroprotective Products Product
Table 57. NeuroVive Pharmaceutical Recent Developments/Updates
Table 58. Ceregene Corporation Information
Table 59. Ceregene Description and Business Overview
Table 60. Ceregene Neuroprotective Products Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 61. Ceregene Neuroprotective Products Product
Table 62. Ceregene Recent Developments/Updates
Table 63. BHR Pharma Corporation Information
Table 64. BHR Pharma Description and Business Overview
Table 65. BHR Pharma Neuroprotective Products Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 66. BHR Pharma Neuroprotective Products Product
Table 67. BHR Pharma Recent Developments/Updates
Table 68. Neuren Pharmaceuticals Corporation Information
Table 69. Neuren Pharmaceuticals Description and Business Overview
Table 70. Neuren Pharmaceuticals Neuroprotective Products Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 71. Neuren Pharmaceuticals Neuroprotective Products Product
Table 72. Neuren Pharmaceuticals Recent Developments/Updates
Table 73. Allon therapeutics Corporation Information
Table 74. Allon therapeutics Description and Business Overview
Table 75. Allon therapeutics Neuroprotective Products Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 76. Allon therapeutics Neuroprotective Products Product
Table 77. Allon therapeutics Recent Developments/Updates
Table 78. Bionure Corporation Information
Table 79. Bionure Description and Business Overview
Table 80. Bionure Neuroprotective Products Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 81. Bionure Neuroprotective Products Product
Table 82. Bionure Recent Developments/Updates
Table 83. Production Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Neuroprotective Products Distributors List
Table 86. Neuroprotective Products Customers List
Table 87. Neuroprotective Products Market Trends
Table 88. Neuroprotective Products Growth Drivers
Table 89. Neuroprotective Products Market Challenges
Table 90. Neuroprotective Products Market Restraints
Table 91. Global Neuroprotective Products Sales Forecast by Type (2022-2027) & (MT)
Table 92. Global Neuroprotective Products Sales Market Share Forecast by Type (2022-2027)
Table 93. Global Neuroprotective Products Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 94. Global Neuroprotective Products Revenue Market Share Forecast by Type (2022-2027)
Table 95. Global Neuroprotective Products Sales Forecast by Application (2022-2027) & (MT)
Table 96. Global Neuroprotective Products Sales Market Share Forecast by Application (2022-2027)
Table 97. Global Neuroprotective Products Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 98. Global Neuroprotective Products Revenue Market Share Forecast by Application (2022-2027)
Table 99. Global Neuroprotective Products Sales Forecast by Region (2022-2027) & (MT)
Table 100. Global Neuroprotective Products Sales Market Share Forecast by Region (2022-2027)
Table 101. Global Neuroprotective Products Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 102. Global Neuroprotective Products Revenue Market Share Forecast by Region (2022-2027)
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Neuroprotective Products
Figure 2. Global Neuroprotective Products Market Share by Type in 2020 & 2027
Figure 3. Cholinesterase inhibitors Product Picture
Figure 4. NMDA receptor antagonists Product Picture
Figure 5. Others Product Picture
Figure 6. Global Neuroprotective Products Market Share by Application in 2020 & 2027
Figure 7. Alzheimer's disease
Figure 8. Multiple sclerosis
Figure 9. Others
Figure 10. Global Neuroprotective Products Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Neuroprotective Products Market Size 2016-2027 (US$ Million)
Figure 12. Global Neuroprotective Products Sales 2016-2027 (MT)
Figure 13. Global Neuroprotective Products Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Neuroprotective Products Sales Share by Manufacturers in 2020
Figure 15. Global Neuroprotective Products Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Neuroprotective Products Players: Market Share by Revenue in 2020
Figure 17. Neuroprotective Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Neuroprotective Products Sales Market Share by Region (2016-2021)
Figure 19. Global Neuroprotective Products Sales Market Share by Region in 2020
Figure 20. Global Neuroprotective Products Revenue Market Share by Region (2016-2021)
Figure 21. Global Neuroprotective Products Revenue Market Share by Region in 2020
Figure 22. U.S. Neuroprotective Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Neuroprotective Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Neuroprotective Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Neuroprotective Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Neuroprotective Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Neuroprotective Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Neuroprotective Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Neuroprotective Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Neuroprotective Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Neuroprotective Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Neuroprotective Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Neuroprotective Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Neuroprotective Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Neuroprotective Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Neuroprotective Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Neuroprotective Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Neuroprotective Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Neuroprotective Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Neuroprotective Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Neuroprotective Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Neuroprotective Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Neuroprotective Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Neuroprotective Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. U.A.E Neuroprotective Products Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Neuroprotective Products by Type (2016-2021)
Figure 47. Sales Market Share of Neuroprotective Products by Application (2016-2021)
Figure 48. Sales Market Share of Neuroprotective Products by Application in 2020
Figure 49. Revenue Share of Neuroprotective Products by Application (2016-2021)
Figure 50. Revenue Share of Neuroprotective Products by Application in 2020
Figure 51. Manufacturing Cost Structure of Neuroprotective Products
Figure 52. Manufacturing Process Analysis of Neuroprotective Products
Figure 53. Neuroprotective Products Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed